Diabetes-related Eye Complications
📧 Sign up to get email alerts when something new happens for Diabetes-related Eye Complications.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-21EMA Authorised: Vabysmo (Faricimab) — Roche Registration GmbH
Vabysmo (faricimab) has been authorised by the EMA for indications including wet age-related macular degeneration, macular edema, and diabet…
-
EMA approval · 2026-08-21EMA Authorised: Rimmyrah (ranibizumab) — Qilu Pharma Spain S.L.
EU authorizes Rimmyrah (ranibizumab) from Qilu Pharma Spain S.L. for indications including wet age-related macular degeneration, macular ede…